Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

MBD2 deficiency does not accelerate p53 mediated lymphomagenesis

Abstract

Recent studies using hypomorphic DNA methyltransferase 1 (DNMT1) alleles have suggested that strategies aiming to reduce DNA methylation may increase genomic instability and lymphomagenesis. Given our recent finding that loss of methyl-binding domain protein 2 (Mbd2) suppresses intestinal tumorigenesis, we have tested whether loss of Mbd2 increases lymphomagenesis by intercrossing Mbd2 deficient mice with p53 deficient and p53 heterozygous mice. Unlike DNMT1, loss of Mbd2 does not accelerate lymphomagenesis, arguing that MBD2 may represent a better potential therapeutic target than DNMT1.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  • Campbell PM, Bovenzi V and Szyf M . (2004). Carcinogenesis, 25, 499–507.

  • Eads CA, Nickel AE and Laird PW . (2002). Cancer Res., 62, 1296–1299.

  • Eden A, Gaudet F, Waghmare A and Jaenisch R . (2003). Science, 300, 455.

  • Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, Dausman J, Gray JW, Leonhardt H and Jaenisch R . (2003). Science, 300, 489–492.

  • Hendrich B, Guy J, Ramsahoye B, Wilson VA and Bird A . (2001). Genes Dev., 15, 710–723.

  • Laird PW, Jackson-Grusby L, Fazeli A, Dickinson SL, Jung WE, Li E, Weinberg RA and Jaenisch R . (1995). Cell, 81, 197–205.

  • Lengauer C . (2003). Science, 300, 442–443.

  • Li E, Bestor TH and Jaenisch R . (1992). Cell, 69, 915–926.

  • Sansom OJ, Berger J, Bishop SM, Hendrich B, Bird A and Clarke AR . (2003). Nat. Genet., 34, 145–147.

  • Sansom OJ and Clarke AR . (2000). Mutat. Res., 452, 149–162.

  • Toft NJ, Curtis LJ, Sansom OJ, Leitch AL, Wyllie AH, te Riele H, Arends MJ and Clarke AR . (2002). Oncogene, 21, 6299–6306.

  • Trinh BN, Long TI, Nickel AE, Shibata D and Laird PW . (2002). Mol. Cell. Biol., 22, 222906–222917.

  • Yang AS, Estecio MR, Garcia-Manero G, Kantarjian HM and Issa JP . (2003). Science, 302, 1153.

Download references

Acknowledgements

This work was supported by CR-UK and the Wales Gene Park.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alan Richard Clarke.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sansom, O., Bishop, S., Bird, A. et al. MBD2 deficiency does not accelerate p53 mediated lymphomagenesis. Oncogene 24, 2430–2432 (2005). https://doi.org/10.1038/sj.onc.1208166

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208166

Keywords

This article is cited by

Search

Quick links